SA519401730B1 - جهاز طبي لعلاج عدوى الفيروس الحليمي البشرى الجلدية - Google Patents

جهاز طبي لعلاج عدوى الفيروس الحليمي البشرى الجلدية

Info

Publication number
SA519401730B1
SA519401730B1 SA519401730A SA519401730A SA519401730B1 SA 519401730 B1 SA519401730 B1 SA 519401730B1 SA 519401730 A SA519401730 A SA 519401730A SA 519401730 A SA519401730 A SA 519401730A SA 519401730 B1 SA519401730 B1 SA 519401730B1
Authority
SA
Saudi Arabia
Prior art keywords
treatment
medical device
papilloma virus
cutaneous infections
human papilloma
Prior art date
Application number
SA519401730A
Other languages
English (en)
Inventor
الينا بولى
Original Assignee
بولى ام دى اس.ار.ال
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT102017000090344A external-priority patent/IT201700090344A1/it
Application filed by بولى ام دى اس.ار.ال filed Critical بولى ام دى اس.ار.ال
Publication of SA519401730B1 publication Critical patent/SA519401730B1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32—Surgical cutting instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32—Surgical cutting instruments
    • A61B2017/320004—Surgical cutting instruments abrasive

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

يتعلق الاختراع الحالي بجهاز طبي medical device لعلاج العدوى الجلدية من الفيروس الحليمي البشري human papilloma virus (HPV)، وبشكل خاص لعلاج السنط warts والأمراض ذات الصلة. وبصفة خاصة، يتعلق الاختراع الحالي بتركيبة ذات قاعدة من الكولوديون collodion-based composition، وبصفة خاصة كولوديون مرن elastic collodion، مشتمل على حمض أسيتيل ساليسيليك acetylsalicylic acid وتركيبة مشتملة على حمض أسيتيل ساليسيليك وجليكول glycol. يمكن استخدام تلك التركيبات في علاج عدوى الفيروس الحليمي البشرى الجلدية، وبشكل خاص العدوى الحميدة benign infections مثل السنط، الأورام الحليمية papillomas والأورام اللقمية condylomas. شكل3
SA519401730A 2017-08-04 2019-05-06 جهاز طبي لعلاج عدوى الفيروس الحليمي البشرى الجلدية SA519401730B1 (ar)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102017000090344A IT201700090344A1 (it) 2017-08-04 2017-08-04 Dispositivo medicale per il trattamento delle infezioni cutanee da hpv
IT201800006535 2018-06-21
PCT/IB2018/055092 WO2019025884A1 (en) 2017-08-04 2018-07-11 MEDICAL DEVICE FOR THE TREATMENT OF PVH SKIN INFECTIONS

Publications (1)

Publication Number Publication Date
SA519401730B1 true SA519401730B1 (ar) 2022-06-16

Family

ID=63103980

Family Applications (1)

Application Number Title Priority Date Filing Date
SA519401730A SA519401730B1 (ar) 2017-08-04 2019-05-06 جهاز طبي لعلاج عدوى الفيروس الحليمي البشرى الجلدية

Country Status (26)

Country Link
US (1) US10993950B2 (ar)
EP (1) EP3509567B1 (ar)
JP (1) JP6989150B2 (ar)
KR (1) KR102533119B1 (ar)
CN (1) CN110267646A (ar)
AU (1) AU2018311360B2 (ar)
BR (1) BR112019008206A2 (ar)
CA (1) CA3042967C (ar)
CL (1) CL2019002082A1 (ar)
CY (1) CY1124098T1 (ar)
DK (1) DK3509567T3 (ar)
ES (1) ES2874590T3 (ar)
HR (1) HRP20210700T1 (ar)
HU (1) HUE054198T2 (ar)
IL (1) IL266451B2 (ar)
LT (1) LT3509567T (ar)
MX (1) MX2019004729A (ar)
NZ (1) NZ753150A (ar)
PL (1) PL3509567T3 (ar)
PT (1) PT3509567T (ar)
RS (1) RS61830B1 (ar)
SA (1) SA519401730B1 (ar)
SI (1) SI3509567T1 (ar)
UA (1) UA123347C2 (ar)
WO (1) WO2019025884A1 (ar)
ZA (1) ZA201904694B (ar)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110327357B (zh) * 2019-08-05 2023-07-07 张文林 一种用于治疗hpv感染的复合制剂及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL121097C (ar) * 1958-04-18
US6703009B1 (en) * 1993-03-30 2004-03-09 Tendskin International Inc. Topical compositions and methods for treating pseudofolliculitis barbae and ingrown hair
US20050019418A1 (en) * 2003-07-23 2005-01-27 Crutchfield Charles E. Wart treatment
US20080312196A1 (en) * 2007-06-15 2008-12-18 Cohen Carl J Topical wart removal composition
MX2012004144A (es) * 2009-10-08 2012-05-08 Msd Consumer Care Inc Composicion de bajo contenido de eter y aparato de administracion.
WO2011076401A1 (de) * 2009-12-23 2011-06-30 Holger Schankin Acetylsalicylsäure-haltige, im wesentlichen wasserfreie pharmazeutische zusammensetzungen
US20120082742A1 (en) * 2010-09-30 2012-04-05 Elorac, Ltd Method and compositions for treating cutaneous verrucae
FR2972928B1 (fr) * 2011-03-25 2013-11-29 Urgo Lab Composition contenant une cellulose, une huile vegetale et un solvant volatil, ses utilisations comme pansement
US8709501B1 (en) * 2011-07-22 2014-04-29 Beverly Jansen Method for treating wounds for mammals, wound healer compound, and method of manufacturing thereof
JP5416297B1 (ja) * 2013-03-07 2014-02-12 由唯 久留米 サリチル酸を添加して孔径制御されたコロジオン膜の褐変抑制方法
AU2016314621B2 (en) * 2015-09-04 2021-05-13 Poli Md S.R.L. Composition and medical device comprising acetylsalicylic acid for the treatment of human papilloma virus skin infections

Also Published As

Publication number Publication date
DK3509567T3 (da) 2021-05-03
CA3042967A1 (en) 2019-02-07
CY1124098T1 (el) 2022-05-27
ZA201904694B (en) 2022-08-31
ES2874590T3 (es) 2021-11-05
RS61830B1 (sr) 2021-06-30
EP3509567B1 (en) 2021-03-24
KR20200037121A (ko) 2020-04-08
AU2018311360B2 (en) 2021-05-27
US20190350946A1 (en) 2019-11-21
IL266451B (en) 2022-10-01
CL2019002082A1 (es) 2020-04-13
CA3042967C (en) 2022-04-05
UA123347C2 (uk) 2021-03-17
LT3509567T (lt) 2021-07-12
PT3509567T (pt) 2021-05-13
US10993950B2 (en) 2021-05-04
BR112019008206A2 (pt) 2019-07-09
IL266451B2 (en) 2023-02-01
WO2019025884A1 (en) 2019-02-07
PL3509567T3 (pl) 2021-10-25
AU2018311360A1 (en) 2019-05-23
HUE054198T2 (hu) 2021-08-30
JP6989150B2 (ja) 2022-01-05
EP3509567A1 (en) 2019-07-17
SI3509567T1 (sl) 2021-08-31
KR102533119B1 (ko) 2023-05-16
CN110267646A (zh) 2019-09-20
HRP20210700T1 (hr) 2021-07-23
IL266451A (en) 2019-06-30
MX2019004729A (es) 2019-08-21
NZ753150A (en) 2022-12-23
JP2020537628A (ja) 2020-12-24

Similar Documents

Publication Publication Date Title
EA201990043A1 (ru) Антибактериальные соединения
MX2021005350A (es) Compuestos de piridazinona y usos de los mismos.
WO2014186742A3 (en) Anhydrous hydrogel composition
EA201590457A1 (ru) Сульфамоил-ариламиды и их применение в качестве лекарственных препаратов для лечения гепатита b
MY162146A (en) Pharmaceutical composition
NZ733174A (en) Quinazoline derivatives used to treat hiv
WO2016070166A3 (en) Messenger una molecules and uses thereof
PH12015502539A1 (en) Cenicriviroc compositions and methods of making and using the same
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
MX2018002732A (es) Composicion y dispositivo medico que comprenden acido acetilsalicilico para el tratamiento de infecciones cutaneas por virus de papiloma humano.
MX2021005348A (es) Compuestos de piridazinonas y usos de los mismos.
MY181928A (en) Sodium channel modulators for the treatment of pain and diabetes
EA201692007A1 (ru) Соединения изоиндолинона в качестве модуляторов gpr119 для лечения диабета, ожирения, дислипидемии и связанных с ними нарушений
EP2555798A4 (en) METHOD AND COMPOSITIONS FOR INHIBITING HIV TRANSMISSIONS
HK1150373A2 (en) Disinfectant and antiseptic formulation having reduced iodine content
GB2476446A (en) Topical treatment of skin infection
MX2013004906A (es) Nuevos inhibidores especificos de la proteasa ns3 de hcv.
NZ709209A (en) Internal ultrasound gel
EA201690594A1 (ru) Состав для лечения вич-инфекции на основе атазанавира и кобицистата
SA519401730B1 (ar) جهاز طبي لعلاج عدوى الفيروس الحليمي البشرى الجلدية
EA201890419A1 (ru) ОТСЕЛЕКТИРОВАННЫЙ АМИД γ-ГИДРОКСИМАСЛЯНОЙ КИСЛОТЫ И ЕГО ПРИМЕНЕНИЯ ПРИ ЛЕЧЕНИИ ЗЛОУПОТРЕБЛЕНИЯ АЛКОГОЛЕМ
EA201690966A1 (ru) Новое соединение для лечения тяжелой гипогликемии
EA201500736A1 (ru) Пиразолилкарбоксамиды i в качестве ингибиторов crac каналов
EA201500737A1 (ru) Пиразолилкарбоксамиды ii в качестве ингибиторов crac каналов
MX2015009348A (es) Composiciones hemostaticas.